Literature DB >> 29632370

A cynomolgus macaque model for Crimean-Congo haemorrhagic fever.

Elaine Haddock1, Friederike Feldmann2, David W Hawman1, Marko Zivcec1,3,4, Patrick W Hanley2, Greg Saturday2, Dana P Scott2, Tina Thomas2, Miša Korva5, Tatjana Avšič-Županc5, David Safronetz1,6, Heinz Feldmann7.   

Abstract

Crimean-Congo haemorrhagic fever (CCHF) is the most medically significant tick-borne disease, being widespread in the Middle East, Asia, Africa and parts of Europe 1 . Increasing case numbers, westerly movement and broadly ranging case fatality rates substantiate the concern of CCHF as a public health threat. Ixodid ticks of the genus Hyalomma are the vector for CCHF virus (CCHFV), an arbovirus in the genus Orthonairovirus of the family Nairoviridae. CCHFV naturally infects numerous wild and domestic animals via tick bite without causing obvious disease2,3. Severe disease occurs only in humans and transmission usually happens through tick bite or contact with infected animals or humans. The only CCHF disease model is a subset of immunocompromised mice4-6. Here, we show that following CCHFV infection, cynomolgus macaques exhibited hallmark signs of human CCHF with remarkably similar viral dissemination, organ pathology and disease progression. Histopathology showed infection of hepatocytes, endothelial cells and monocytes and fatal outcome seemed associated with endothelial dysfunction manifesting in a clinical shock syndrome with coagulopathy. This non-human primate model will be an invaluable asset for CCHFV countermeasures development.

Entities:  

Mesh:

Year:  2018        PMID: 29632370      PMCID: PMC6717652          DOI: 10.1038/s41564-018-0141-7

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  30 in total

Review 1.  The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa.

Authors:  H Hoogstraal
Journal:  J Med Entomol       Date:  1979-05-22       Impact factor: 2.278

2.  Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever.

Authors:  Mustafa Aydin Cevik; Ayşe Erbay; Hürrem Bodur; Selim Sirri Eren; Esragül Akinci; Kenan Sener; Pinar Ongürü; Ayhan Kubar
Journal:  Clin Infect Dis       Date:  2007-08-23       Impact factor: 9.079

3.  Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.

Authors:  P Onguru; S Dagdas; H Bodur; M Yilmaz; E Akinci; S Eren; G Ozet
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 4.  Crimean-Congo hemorrhagic fever.

Authors:  Chris A Whitehouse
Journal:  Antiviral Res       Date:  2004-12       Impact factor: 5.970

5.  Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice.

Authors:  Sándor Bereczky; Gunnel Lindegren; Helen Karlberg; Sara Akerström; Jonas Klingström; Ali Mirazimi
Journal:  J Gen Virol       Date:  2010-02-17       Impact factor: 3.891

6.  Crimean-Congo hemorrhagic fever.

Authors:  Regina Vorou; Ioannis N Pierroutsakos; Helen C Maltezou
Journal:  Curr Opin Infect Dis       Date:  2007-10       Impact factor: 4.915

7.  Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever.

Authors:  Onder Ergonul; Semra Tuncbilek; Nurcan Baykam; Aysel Celikbas; Basak Dokuzoguz
Journal:  J Infect Dis       Date:  2006-02-22       Impact factor: 5.226

8.  Viral load as predictor of Crimean-Congo hemorrhagic fever outcome.

Authors:  Darja Duh; Ana Saksida; Miroslav Petrovec; Salih Ahmeti; Iusuf Dedushaj; Marcus Panning; Christian Drosten; Tatjana Avsic-Zupanc
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

9.  The complete genome sequence of a Crimean-Congo hemorrhagic fever virus isolated from an endemic region in Kosovo.

Authors:  Darja Duh; Stuart T Nichol; Marina L Khristova; Ana Saksida; Iva Hafner-Bratkovic; Miroslav Petrovec; Iusuf Dedushaj; Salih Ahmeti; Tatjana Avsic-Zupanc
Journal:  Virol J       Date:  2008-01-15       Impact factor: 4.099

Review 10.  Crimean-Congo haemorrhagic fever.

Authors:  Onder Ergönül
Journal:  Lancet Infect Dis       Date:  2006-04       Impact factor: 25.071

View more
  29 in total

1.  Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques.

Authors:  Veronica V Nicholas; Rebecca Rosenke; Friederike Feldmann; Dan Long; Tina Thomas; Dana P Scott; Heinz Feldmann; Andrea Marzi
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

2.  Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.

Authors:  David W Hawman; Kimberly Meade-White; Elaine Haddock; Rumi Habib; Dana Scott; Tina Thomas; Rebecca Rosenke; Heinz Feldmann
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

3.  Infection Route Impacts the Pathogenesis of Severe Fever with Thrombocytopenia Syndrome Virus in Ferrets.

Authors:  Su-Jin Park; Young-Il Kim; Mark Anthony Casel; Eun-Ha Kim; Se-Mi Kim; Kwang-Min Yu; Rare Rollon; Seung-Gyu Jang; Hye Won Jeong; Young Ki Choi
Journal:  Viruses       Date:  2022-05-29       Impact factor: 5.818

Review 4.  Immunobiology of Crimean-Congo hemorrhagic fever.

Authors:  Sergio E Rodriguez; David W Hawman; Teresa E Sorvillo; T Justin O'Neal; Brian H Bird; Luis L Rodriguez; Éric Bergeron; Stuart T Nichol; Joel M Montgomery; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2022-01-11       Impact factor: 10.103

5.  Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.

Authors:  Jessica R Spengler; Stephen R Welch; Florine E M Scholte; JoAnn D Coleman-McCray; Jessica R Harmon; Stuart T Nichol; Éric Bergeron; Christina F Spiropoulou
Journal:  Antiviral Res       Date:  2019-08-01       Impact factor: 5.970

6.  Differential Growth Characteristics of Crimean-Congo Hemorrhagic Fever Virus in Kidney Cells of Human and Bovine Origin.

Authors:  Katalin Földes; Touraj Aligholipour Farzani; Koray Ergünay; Aykut Ozkul
Journal:  Viruses       Date:  2020-06-25       Impact factor: 5.048

Review 7.  Recent advances in understanding Crimean-Congo hemorrhagic fever virus.

Authors:  David W Hawman; Heinz Feldmann
Journal:  F1000Res       Date:  2018-10-29

8.  Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever.

Authors:  J Maximilian Fels; Daniel P Maurer; Andrew S Herbert; Ariel S Wirchnianski; Olivia Vergnolle; Robert W Cross; Dafna M Abelson; Crystal L Moyer; Akaash K Mishra; Jennifer T Aguilan; Ana I Kuehne; Noel T Pauli; Russell R Bakken; Elisabeth K Nyakatura; Jan Hellert; Gregory Quevedo; Leslie Lobel; Stephen Balinandi; Julius J Lutwama; Larry Zeitlin; Thomas W Geisbert; Felix A Rey; Simone Sidoli; Jason S McLellan; Jonathan R Lai; Zachary A Bornholdt; John M Dye; Laura M Walker; Kartik Chandran
Journal:  Cell       Date:  2021-06-01       Impact factor: 66.850

9.  Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis.

Authors:  Charlene Ranadheera; Emelissa J Valcourt; Bryce M Warner; Guillaume Poliquin; Kyle Rosenke; Kathy Frost; Kevin Tierney; Greg Saturday; Jinxin Miao; Jonna B Westover; Brian B Gowen; Stephanie Booth; Heinz Feldmann; Zhongde Wang; David Safronetz
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.996

10.  Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys.

Authors:  Robert W Cross; Abhishek N Prasad; Viktoriya Borisevich; Joan B Geisbert; Krystle N Agans; Daniel J Deer; Karla A Fenton; Thomas W Geisbert
Journal:  PLoS Negl Trop Dis       Date:  2020-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.